Elhilali M M, Nayak S K
Urology. 1976 May;7(5):488-91. doi: 10.1016/0090-4295(76)90185-0.
Attempts to obtain cell lines from bladder and renal cancer patients were done in 42 patients, with success to obtain primary cultures in 25 and long-term cultures in 7. Cell-mediated and humoral immunity was demonstrated in both tumors by microcytotoxicity in vitro. No cytotoxicity could be deomonstrated against target cells obtained from metastatic cancer tissue. Abrogation of cell-mediated immunity by serum factors was demonstrated. No recurrence was obtained in the group of patients showing positive lymphocytotoxicity during follow-up.
对42例膀胱癌和肾癌患者进行了获取细胞系的尝试,成功获得原代培养物的有25例,获得长期培养物的有7例。通过体外微量细胞毒性试验在两种肿瘤中均证实了细胞介导免疫和体液免疫。对从转移性癌组织获得的靶细胞未显示出细胞毒性。证实血清因子可消除细胞介导免疫。在随访期间淋巴细胞毒性呈阳性的患者组中未出现复发。